Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.

NCT02060565 is registered in ClinicalTrials.gov with Association HGE CHU Bordeaux Sud as lead sponsor.

NCT NCT02060565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02060565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.
Lead sponsor
Association HGE CHU Bordeaux Sud
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2014
Completion date
February 28, 2034
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease